Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Scientific Reports|October 22, 2024
Cycling versus swapping strategies with TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practiceFederica Lumetti, Alarico Ariani, Antonio Marchesoni, et al.
Drug Design, Development and Therapy|February 2, 2017
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to dateChiara Crotti, Maria Gabriella Raimondo, Andrea Becciolini, et al.
Autoimmunity Reviews|October 18, 2017
The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectivesEnnio Giulio Favalli, Maria Gabriella Raimondo, Andrea Becciolini, et al.
Acta Bio-Medica : Atenei Parmensis|May 4, 2021
A Parsonage-Turner Syndrome secondary to Parvovirus B19 infectionFlavio Mozzani, Noemi Giuliana Marino, Andrea Becciolini, et al.
The Journal of Rheumatology|December 3, 2016
The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical SettingMarco Di Carlo, Andrea Becciolini, Valentina Lato, et al.
Drug Design, Development and Therapy|July 20, 2017
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeabilityAndrea Becciolini, Maria Gabriella Raimondo, Chiara Crotti, et al.
Clinical Reviews in Allergy & Immunology|January 27, 2018
Sex and Management of Rheumatoid ArthritisEnnio Giulio Favalli, Martina Biggioggero, Chiara Crotti, et al.
Drug Design, Development and Therapy|June 7, 2018
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registryEnnio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, et al.
Modern Rheumatology|September 8, 2017
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitorsSara Monti, Monica Todoerti, Veronica Codullo, et al.
Arthritis Care & Research|November 12, 2015
Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local RegistryEnnio Giulio Favalli, Francesca Pregnolato, Martina Biggioggero, et al.
Pageof 7